International drug makers are expected to produce three billion doses of the H1N1 (swine flu) vaccine, “enough for just under half the world’s population,” a WHO official said Thursday, Canwest News Service/Ottawa Citizen reports. “The agency was hoping pharmaceutical companies would be able to make about five billion doses a year, but data collected over the summer led to the revised estimate,” the news service writes.
Pneumonia & Flu
A team of health experts on Tuesday called for the U.S. “to lead a global effort to protect people from new outbreaks of deadly infectious diseases that originate in animals, such as swine flu, AIDS and SARS,” Reuters writes.
During the WHO Asia-Pacific regional meeting Monday, WHO Director-General Margaret Chan discussed the organization’s efforts to ensure that poor nations have access to H1N1 vaccines, VOA News reports (Bayron, 9/21). ABC Radio Australia reports Chan is seeking “three billion doses of swine flu vaccine to be made available worldwide, especially in developing countries where it still poses a serious risk” (9/22).
The U.N. this week will request that wealthy nations and development banks donate $1.48 billion to the help developing countries fight H1N1 (swine flu), Bloomberg reports.
Lancet Editorial, Comment Address Climate Change, Health In addition to the Lancet’s recent publication of an opinion piece and letter by 18 doctor association leaders about the potential health risks associated with climate change, the journal includes an editorial about sexual and reproductive health and climate change and a comment…
A group of nine countries on Thursday announced they would share H1N1 (swine flu) vaccine supplies with developing nations to protect the world’s poorest from the H1N1 virus, Reuters reports. The U.S. joined Australia, Brazil, France, Italy, New Zealand, Norway, Switzerland, and Britain in the pledge, according to the news service. The new donations add to the 120 million vaccine doses pharmaceutical companies GlaxoSmithKline and Sanofi-Pasteur pledged to WHO.
The recent news that a single dose of H1N1 (swine flu) vaccine can protect adults against the virus has sparked conversations between the WHO and developed countries about sharing their vaccine stockpiles with developing countries, Bloomberg reports.
HHS Secretary Kathleen Sebelius announced Tuesday during a House Energy and Commerce Committee hearing that H1N1 (swine flu) vaccines produced by four manufacturers — CSL Ltd., Novartis, Sanofi-Pasteur and Medimmune — had won FDA approval, paving the way for a U.S. large-scale vaccination campaign, the Wall Street Journal reports. The application for GlaxoSmithKline PLC’s vaccine is still being considered.
Also In Global Health News: PNG, Nepal Outbreaks; Taliban OKs Polio Vaccination; Technology Helps In Developing Countries; Satellite Images For Malaria Control
Outbreaks Strain Papua New Guinea’s Health System VOA News examines the ongoing struggle for Papua New Guinea’s health system to treat thousands of people infected by the “simultaneous outbreaks of influenza, dysentery and cholera that have killed about 120 people.” The article includes information about the difficulties heath officials are…
Recent findings that a single dose of an H1N1 (swine) flu vaccine offers protection against the virus and anticipation of vaccination programs starting earlier than predicted will increase the number of people worldwide with access to the vaccine and the likelihood health officials may be able to control the spread of the virus, Bloomberg reports.